CREATINE-HCL
Natural health product licensed in Canada
- Licence holder
- SAGA Sciences Canada, Inc.
- NPN or DIN-HM
- 80032032
- Status
- Active licence
- Licence date
- 7 May 2012
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-(Aminoiminométhyl)-N-méthylglycine monohydraté Source : Créatine monohydratée | 750 milligramme | Not calculated |
Non-medicinal ingredients
Acide citrique, Acésulfame potassium, Saveur de framboise, Acide L-malique, Sucralose, Saveur de limonade
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Mesures | 2 days |
Uses authorised in Canada
Increases muscle mass when used in conjunction with a resistance training regimen. Improves strength, power and performance in repetitive bouts of brief, highly-intense physical activity (e.g. sprints, jumping, resistance training) by increasing intramuscular phosphocreatine levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80032032
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.